May 13, 2019
Mitsubishi Tanabe President Masayuki Mitsuka Mitsubishi Tanabe Pharma said on May 10 that it is braced for a whopping 82% drop in core operating profit for this fiscal year ending March 2020 due to an ongoing arbitration process over Novartis’...read more